Image

PET Imaging Evaluation of [11C]SY08

Join our study to explore [11C]SY08 using PET imaging.

Recruiting
50-80 years
All
Phase 0
**Study Summary** This research study is examining a new tool called **[11C]SY08**, used in a type of brain scan called **PET imaging**. PET stands for *Positron Emission Tomography*, a special test that helps doctors see detailed images of the brain. The study aims to see how well this tool works in detecting a protein called **alpha synuclein (αS)**, which builds up in the brains of people with certain diseases like Parkinson's Disease (PD), Multiple System Atrophy (MSA), and Dementia with Lewy Bodies (DLB). Participants in the study will receive a small injection of [11C]SY08 and will have a PET scan to see how the substance spreads in the brain. **Key Points:** - The study is open to people aged 50-80, including both healthy individuals and those with PD, MSA, or DLB. - Participants will need to attend one PET/MRI scanning session; this can take up to 90 minutes. - The study is not suitable for those with certain health conditions or those who cannot safely undergo a PET scan. Participants must meet specific health criteria and should not have recently had major surgery or certain psychiatric conditions.
Study details
    Parkinson's Disease
    Multiple System Atrophy
    Dementia With Lewy Bodies
    Healthy Controls

NCT06098612

Massachusetts General Hospital

17 April 2026

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team


Email

View email

Phone

Phone country flag

View phone
Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.